Agree Timely, extremely hard to put a value on their near term and long term potential.
In some ways a pity were are still in the extended SPP with the new CEO announcement, because that puts the breaks on currently wading through the day/short term traders and debt recoveries early, in the next coouple of levels up, to then enjoy larger advances with the next announcements.
However, this announcement, then combined with the likely near future announcements of further development eg Kidneyvital, Telemdcare, HDA, etc., and subsequnetly some feed back on contracts and pharmacy sales, NOW makes the SPP very attractive.
Gotta say it again : Great Products (with ?25 more to come) and Great ?Team? (which just keeps getting better and better) !
STI Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
